30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Gary Lyons

Track

Insider profile

Currently holds positions in Brickell Biotech Inc, Travere Therapeutics Inc, Rigel Pharmaceuticals Inc and Neurocrine Biosciences Inc

Performance

Overall performance
2.2
Performance over holding periods
2.2
30 days 90 days 120 days
Average return -1% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Director Brickell Biotech Inc Aug. 31, 2019 -
Independent Chairman of the Board Travere Therapeutics Inc May 18, 2016 -
Independent Director Rigel Pharmaceuticals Inc Oct. 6, 2005 -
Independent Director Neurocrine Biosciences Inc Jan. 14, 2008 -
Independent Director Brickell Biotech Inc March 1, 1997 - Aug. 31, 2019
Independent Director Plus Therapeutics Inc Oct. 7, 2013 - Jan. 30, 2019
Independent Director Travere Therapeutics Inc Oct. 9, 2014 - May 18, 2016
Independent Director Humanigen Inc Jan. 1, 2011 - Nov. 19, 2015
Director Poniard Pharmaceuticals Inc July 9, 2009 - Jan. 3, 2012
Gary Lyons's trades of Travere Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-16 2026-04-14
PlS Planned sale
75,273 +31.2%
67.64
US$4,827,347 		75,273 +31.2% 67.64 US$4,827,347
2026-04-14 2026-04-14
PrS Proposed sale
29,048
323.79
US$2,160,707 		29,048 323.79 US$2,160,707
2025-12-04 2025-12-03
PlS Planned sale
31,800 -39.1%
465.21
US$300,481 		31,800 -39.1% 465.21 US$300,481
2025-12-03 2025-12-03
PrS Proposed sale
15,000
152.48
US$2,287,200 		15,000 152.48 US$2,287,200
2024-10-04 2024-10-04
PrS Proposed sale
40,000
13.65
US$546,000 		40,000 13.65 US$546,000
2024-10-04 2024-10-04
PlS Planned sale
18,821 -27.0%
15.15
US$285,227 		18,821 -27.0% 15.15 US$285,227
2024-10-04 2024-10-04
PlS Planned sale
21,179 -23.3%
14.35
US$303,874 		21,179 -23.3% 14.35 US$303,874
2024-08-15 2024-08-13
PlS Planned sale
11,570 -8.9%
150.43
US$1,740,450 		11,570 -8.9% 150.43 US$1,740,450
2024-07-18 2024-07-16
PlS Planned sale
930 -0.8%
150.03
US$139,530 		930 -0.8% 150.03 US$139,530
2024-07-16 2024-07-16
PrS Proposed sale
12,500
147.46
US$1,843,250 		12,500 147.46 US$1,843,250
2024-05-16 2024-05-14
PlS Planned sale
12,500 -9.7%
135.63
US$1,695,370 		12,500 -9.7% 135.63 US$1,695,370
2024-05-14 2024-05-14
PrS Proposed sale
12,500
136.15
US$1,701,875 		12,500 136.15 US$1,701,875
2023-12-27 2023-12-22
PlS Planned sale
10,000 -4.9%
130.04
US$1,300,443 		10,000 -4.9% 130.04 US$1,300,443
2023-12-22 2023-12-22
PrS Proposed sale
10,000
121.16
US$1,211,600 		10,000 121.16 US$1,211,600
2023-12-05 2023-12-01
PlS Planned sale
5,000 -2.4%
116.77
US$583,837 		5,000 -2.4% 116.77 US$583,837
2023-12-01 2023-12-01
PrS Proposed sale
5,000
116.59
US$582,950 		5,000 116.59 US$582,950
2023-09-14 2023-09-12
PlS Planned sale
5,000 -2.4%
115.02
US$575,120 		5,000 -2.4% 115.02 US$575,120
2023-09-12 2023-09-12
PrS Proposed sale
5,000
109.64
US$548,200 		5,000 109.64 US$548,200
2023-09-06 2023-09-01
PlS Planned sale
5,000 -2.4%
110.06
US$550,316 		5,000 -2.4% 110.06 US$550,316
2023-09-01 2023-09-01
PrS Proposed sale
5,000
108.89
US$544,450 		5,000 108.89 US$544,450
2022-11-02 2022-10-31
PlS Planned sale
15,000 -6.9%
114.76
US$1,721,403 		15,000 -6.9% 114.76 US$1,721,403
2022-10-05 2022-10-04
PlS Planned sale
5,000 -2.4%
110.54
US$552,711 		5,000 -2.4% 110.54 US$552,711
2022-04-27 2022-04-25
PlS Planned sale
15,000 -6.7%
92.76
US$1,391,392 		15,000 -6.7% 92.76 US$1,391,392
2021-10-12 2021-10-07
PlS Planned sale
5,000 -2.3%
105.06
US$525,294 		5,000 -2.3% 105.06 US$525,294
2021-06-14 2021-06-10
PlS Planned sale
10,000 -4.5%
100.27
US$1,002,743 		10,000 -4.5% 100.27 US$1,002,743
2021-01-27 2021-01-26
PlS Planned sale
400 -0.2%
120.00
US$48,000 		400 -0.2% 120.00 US$48,000
2021-01-27 2021-01-25
PlS Planned sale
1,600 -0.7%
120.03
US$192,047 		1,600 -0.7% 120.03 US$192,047
2019-11-05 2019-11-01
PlS Planned sale
5,000 -2.1%
100.22
US$501,104 		5,000 -2.1% 100.22 US$501,104
2019-07-31 2019-07-30
PlS Planned sale
10,000 -4.1%
92.07
US$920,686 		10,000 -4.1% 92.07 US$920,686
2016-12-07 2016-12-05
S Sale
7,078 -47.5%
2.30
US$16,248 		7,078 -47.5% 2.30 US$16,248
2013-05-28 2013-05-23
B Purchase
5,953 +10.4%
0.01
US$60 		5,953 +10.4% 0.01 US$60
2011-05-31 2011-05-26
B Purchase
18,750 +60.0%
0.01
US$188 		18,750 +60.0% 0.01 US$188
2010-05-27 2010-05-25
B Purchase
18,750 +150.0%
0.01
US$188 		18,750 +150.0% 0.01 US$188
2004-07-02 2004-07-01
PlS Planned sale
2,500 -0.4%
51.00
US$127,500 		2,500 -0.4% 51.00 US$127,500
2004-07-02 2004-07-01
PlS Planned sale
1,250 -0.2%
51.08
US$63,851 		1,250 -0.2% 51.08 US$63,851
2004-07-02 2004-07-01
PlS Planned sale
1,250 -0.2%
51.35
US$64,188 		1,250 -0.2% 51.35 US$64,188
2004-07-02 2004-07-01
PlS Planned sale
5,000 -0.8%
51.75
US$258,750 		5,000 -0.8% 51.75 US$258,750
2004-05-05 2004-05-03
PlS Planned sale
5,000 -0.8%
62.75
US$313,750 		5,000 -0.8% 62.75 US$313,750
2004-05-05 2004-05-03
PlS Planned sale
5,000 -0.8%
62.50
US$312,500 		5,000 -0.8% 62.50 US$312,500